e national institute for health and care excellence ( nice ) has published formal guidance recommending nalmefene , following draft guidance released in october , which means that patients have the right to request the drug if they meet certain requirements . newline_char nalmefene , also called selincro , is suitable for anyone who regularly drinks high amounts of alcohol , which is defined by the world health organisation as 7.5 units a day for men and five units a day for women . newline_char the pill costs Â£3 , can be taken up to once a day , and is designed to be used whenever the patient wants to stave off the desire to drink . newline_char data released yesterday for scotland , where nalmefene was approved for use in october last year , show that only 53 people were prescribed the drug in 2013/14 . newline_char the 35,000 figure is based on the prediction that 58,000 people are expected to receive psychosocial intervention for mild alcohol dependency , of whom 60 % will be given nalmefene . newline_char we are pleased to be able to recommend the use of namelfene to support people further in their efforts to fight alcohol dependence . story_separator_special_tag the national institute for health and clinical excellence has approved the use of nalmefene , also called selincro , to curb men and women drinking more than the required 7.5 units and 5 units a day limit . newline_char the institute said the drug has been approved for use alongside counselling support for people , who want to reduce their alcohol intake by up to 1.8 units a day . newline_char we are pleased to be able to recommend the use of namelfene to support people further in their efforts to fight alcohol dependence , " she said .
